- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- Pre-launch efforts linked to lasting drug awareness edge: report
- AHA: Cyber resilience critical to prevent nation-state hacks
- Elevance senior executive fights DOJ deposition bid in Medicare Advantage fraud case
- A split is emerging in healthcare’s workforce pipeline
- The hospitals, health systems cutting jobs in 2026
- 19 women making moves in healthcare
- Judy Faulkner’s long game: An Epic that no one can buy
- Why WakeMed’s CEO says his system will ‘survive’ but not ‘thrive’ alone
- NYC invests $12M in overdose recovery workforce
- Epic’s biggest moves in 2026 so far
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Providence raises $500M in philanthropy in 2025
- New York system opens outpatient pavilion
- ‘We cannot cut our way to success’: Hospitals prep for Medicaid crunch
- What cardiology ASCs still haven’t mastered
- Texas dental practice relocates into 6K-square-foot facility
- Surgery Partners opens 9 ASCs in 12 months amid ‘fickle’ M&A market
- Medit launches global orthodontics division, acquires California training institute
- What’s going on behind ASC de novo development?
- Pennsylvania enacts dental faculty bill
- Payer denials remain elevated, but aren’t accelerating: Tenet
- Dental industry eyes increased payer oversight, transparency: 4 updates
- Dr. Michael Durbin named president of the American Association of Orthodontists
- Arkansas dental school launches partnership with children’s hospital
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Woodside Health acquires 40K-square-foot MOB
- Remarks at the 13th Annual Conference on Financial Market Regulation
- Eko Health appoints cardiologist as chief medical officer
- 5 best practices for financially integrating behavioral health
- North Carolina physician practice acquired
- Straine Dental unifies 3 operating companies under single brand
- Thomas Jefferson University to launch new nurse anesthesia program
- Inside this state’s ‘evolving’ noncompete policy
- Is dentistry losing its spark?
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Wisconsin releases statewide mental health action plan: 4 things to know
- Nebraska Medicaid patients struggle to access care as dentists drop out: 6 notes
- Alabama behavioral health provider opens outpatient clinic
- Oscar Health's profit hits $679M, membership rises in Q1
- Kaiser Permanente eases ‘last mile to licensure’ for mental health workers
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- Cannabis most commonly microdosed substance in US: Study
- FDA Authorizes Fruit-Flavored Vapes for Adults
- White House outlines drug control strategy: What healthcare leaders should know
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Inside the gaps in fertility and surrogacy systems
- Lilly to invest $4.5B more into massive Indiana manufacturing complex
- CVS execs say company on track to meet MA margin goals by 2028
- Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- California hospitals sue Anthem over out-of-network care policy
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- UnitedHealthcare to reduce prior auth requirements by 30%
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
- Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
- Newly formed Keenova launches ‘Don't Be a Viking’ campaign for Dupuytren’s contracture
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- Healthcare Dealmakers—UConn Health grows, Centene subsidiaries merge and more
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
Dr. Joseph Varon, M.D. is a prominent critical care physician Houston, Texas. He has made significant contributions to the field of medicine, particularly during the COVID-19 pandemic. His current positions are:
- Chief of Staff at United Memorial Medical Center
- Chairman of the Board at United General Hospital
- President of the Independent Medical Alliance
- Professor of Acute and Continuing Care at the University of Texas Health Science Center in Houston
- Clinical Professor of Medicine at the University of Texas Medical Branch in Galveston
Dr. Varon takes exception to the muzzling of physicians which began during the COVID pandemic as public health officers ruthlessly stifled all medical challenges to politically approved treatments:
https://brownstone.org/articles/what-covid-policy-did-to-doctors-who-refused-to-stay-silent/
What Covid Policy Did to Doctors Who Refused to Stay Silent
By Joseph Varon - March 14, 2026The sound I remember most from the early days of Covid-19 is not the alarms. It was the silence between them. Intensive care units became Covid wards. Monitors glowed in dark rooms while ventilators pushed air into failing lungs. Nurses, shrouded in protective gear, moved quietly. Families were absent—barred from being with loved ones in their final hours.
One night at 3 am, I stood by a patient whose oxygen levels were steadily falling. Outside the room, another patient crashed. Down the hall, a third awaited intubation. For months, this was every night. For 715 consecutive days, I worked in that environment without taking a single day off. In moments like that, medicine becomes very simple. There are no politics in an ICU at 3 am. There is only a physician and a patient, and the responsibility to do everything possible to keep that patient alive.
That philosophy has guided physicians for generations. It is the foundation of clinical medicine: when a patient is dying, you explore every reasonable option that might help.
Yet during Covid, something extraordinary happened. What made the shift so jarring was not simply the presence of disagreement. Physicians have always disagreed. In fact, disagreement is the normal language of medicine. Grand rounds exist for that reason. Journal clubs exist for that reason. The entire structure of scientific publication—from peer review to replication—exists because medicine advances through argument, not obedience. During the pandemic, however, the culture of medicine changed almost overnight. Instead of asking whether a treatment might work, institutions began asking whether discussing that treatment might create the wrong public message. The priority quietly shifted from discovery to control.
Scientific debate faded. Physicians who questioned policies or explored treatments were treated as threats rather than colleagues. Instead of debate, there was enforcement.
Hospitals warned physicians to stay quiet. Medical boards hinted at disciplinary action. Social media platforms censored discussion of therapies that doctors around the world were actively studying. Media outlets portrayed dissenting physicians as reckless or dangerous. What had once been normal scientific discourse was suddenly labeled misinformation.
To physicians trained in earlier decades, this shift was deeply unsettling. Medicine has always lived with uncertainty. Treatments begin as hypotheses and evolve through observation and debate. During the AIDS crisis, clinicians tried multiple strategies before effective therapies emerged. The same was true for sepsis, trauma care, and organ transplantation. No one expected immediate unanimity. Yet during Covid, uncertainty itself became suspect. If a physician acknowledged that evidence was incomplete—or that clinical experience suggested alternative approaches—those statements were sometimes interpreted as challenges to authority rather than contributions to knowledge.
For those of us working inside the ICU, the shift was startling. Medicine had always thrived on disagreement. Physicians argued over treatment strategies, debated emerging evidence, and learned from one another’s experiences. The process was messy, sometimes loud, and occasionally uncomfortable—but it was also the engine of medical progress. During Covid, that process was replaced by something else entirely: the expectation of unanimity. I experienced this transformation firsthand.
During the pandemic, I spoke publicly about what I was seeing inside the ICU—what treatments appeared to help, what policies seemed ineffective, and why physicians needed the freedom to treat patients according to their clinical judgment.
Those comments triggered a reaction that made clear how medical freedom—a core value of our profession—had come under threat. Professional attacks followed, and colleagues were pressured to distance themselves. Invitations disappeared. Media narratives were constructed that bore little resemblance to the reality many of us were witnessing inside hospitals. But perhaps the most revealing response was silence.
Privately, many physicians admitted that the environment had become toxic for honest scientific discussion. In quiet conversations they would agree that open debate had been replaced by institutional pressure. Publicly, however, very few were willing to risk speaking. I chose not to remain silent.
That silence did not necessarily mean physicians agreed with what was happening. More often it meant they understood the risks of speaking. Hospitals depend on reputations. Universities depend on funding. Physicians depend on licenses. When the boundaries of acceptable opinion begin to narrow, most professionals instinctively step back. It is not cowardice; it is survival. But the cumulative effect of that silence is profound. When enough physicians remain quiet, the illusion of consensus begins to replace the reality of debate.
Over the course of the pandemic, I gave more than 4,000 television and media interviews, attempting to explain what physicians were seeing on the front lines and defending the principle that doctors must be allowed to think, question, and treat patients according to their best clinical judgment. The experience was both exhausting and illuminating. Again and again, I found myself explaining basic principles of medicine to audiences who had been told that questioning official policy was somehow dangerous.
Medicine has never advanced through silence. Every major breakthrough in medical history, from antibiotics to organ transplantation, began with physicians willing to challenge prevailing assumptions. Scientific progress depends on disagreement. It requires physicians to ask uncomfortable questions and explore possibilities that established authorities may initially reject. When debate is replaced by enforced consensus, science ceases to function.
That decision to speak carried consequences. Professionally and financially, the cost was substantial. The controversy surrounding Covid treatment debates resulted in lost opportunities, canceled collaborations, and significant professional retaliation. The economic impact was severe, resulting in roughly a 60 percent reduction in my income, a consequence that continues to this day.
Financial pressure has always been one of the most effective tools for enforcing conformity in any profession. Medicine is no exception. Physicians spend decades training, accumulate significant professional responsibilities, and depend on institutional relationships to practice. When controversy threatens those relationships, the safest option is often to say nothing. Many doctors understood this reality during Covid. Some quietly expressed agreement in private conversations but made clear they could not say so publicly. In that environment, silence became the profession’s default posture. For many physicians, that kind of pressure is enough to ensure silence. But the financial cost was never the hardest part.
What made the experience even more disturbing was watching what happened to colleagues who chose to speak openly. Some physicians lost hospital privileges almost overnight. Others faced medical board investigations triggered not by patient complaints, but by their public statements or willingness to question prevailing policies. Careers built over decades were suddenly placed under threat. A number of doctors saw research collaborations vanish, academic appointments quietly withdrawn, and professional reputations publicly attacked. The message became unmistakable: disagreement would carry consequences.
The personal toll was often even greater. Financial pressure, professional isolation, and relentless public scrutiny spilled into physicians’ private lives. I watched colleagues struggle as marriages fractured under the strain of media attacks, legal battles, and the sudden collapse of careers they had spent their lives building. Some left clinical practice entirely. Others retreated from public discussion simply to protect their families. The pandemic revealed something few physicians had previously experienced—the realization that speaking honestly about patient care could place not only one’s career at risk, but one’s personal life as well.
The hardest part was watching medicine surrender one of its most essential principles: the freedom to think and speak for patients. The pandemic response exposed how vulnerable modern medicine has become to political pressure, institutional fear, and media narratives. Decisions that should have remained within the realm of clinical judgment were increasingly dictated by bureaucratic authority.
In theory, medicine is guided by science. In practice, during Covid, it often appeared to be guided by messaging. That realization has prompted an important effort to document what happened during the pandemic and to ensure that physicians’ experiences are not erased from the historical record. One such effort is the COVID Justice initiative, which seeks to collect and document the stories of doctors, nurses, scientists, and patients affected by pandemic policies. The COVID Justice Resolution is an attempt to ensure that the suppression of scientific debate, the censorship of physicians, and the professional retaliation many experienced are openly acknowledged rather than quietly forgotten. The goal is not vengeance. It is accountability and transparency.
If the medical profession refuses to confront what happened during the pandemic—if it pretends that physicians were not pressured, censored, or punished—then the same mistakes will almost certainly be repeated during the next public health crisis.
History shows that institutions rarely correct themselves without accountability. On the front lines, many of us witnessed something deeply troubling: modern medicine’s increasing dependence on bureaucratic authority. When that authority collides with bedside care, physicians can find themselves forced to choose between professional safety and patient advocacy. Every doctor eventually faces that choice. During Covid, many of us faced it together. Some chose silence. Others chose to speak.
Speaking came with consequences. It costs reputations, careers, and, in many cases, substantial income. But the alternative—remaining silent while scientific debate was suppressed and physicians were discouraged from thinking independently—would have been a far greater betrayal of the profession.
Medicine cannot survive if doctors fear speaking freely and challenging consensus on behalf of their patients.
The next public health crisis will come. That is inevitable. When it does, the profession must remember what happened during Covid: how easily fear can replace reason, how quickly debate can be labeled dangerous, and how fragile scientific freedom becomes when institutions decide that certain questions are no longer allowed.
The real lesson of the pandemic is not about a virus. It is about the courage required to defend the integrity of medicine itself. Physicians must remain free to question, to debate, and to innovate in the service of their patients. Without that freedom, medicine becomes little more than bureaucratic compliance dressed in a white coat. And patients deserve far better than that. Because when physicians lose the freedom to question, patients lose something far more precious: the possibility that someone, somewhere, will be willing to challenge the rules in order to save their life.
That is the real price of speaking. The only question now is whether the medical profession still has the courage to pay it.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















